← Back to Search

Moderate-Intensity Aerobic Exercise Intervention for Breast Cancer (EPICC Trial)

N/A
Waitlist Available
Led By Kirk I Erickson, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6 months
Awards & highlights

EPICC Trial Summary

This trial will study whether exercise improves cognitive function in postmenopausal women with early-stage breast cancer.

Eligible Conditions
  • Breast Cancer

EPICC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cognitive Function
Secondary outcome measures
Anxiety
Depressive Symptoms
Estradiol (E2) Levels
+5 more
Other outcome measures
Change in White Matter Microstructure
Changes in Prefrontal Cortex
Changes in Resting State Network
+1 more

EPICC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Moderate-intensity aerobic exerciseExperimental Treatment1 Intervention
Participants engage in a supervised 6-month moderate-intensity aerobic exercise intervention.
Group II: Usual CareActive Control1 Intervention
Physical activity neither limited nor withheld. Participants engage in activity in the same manner as if they were not part of an active intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Moderate-Intensity Aerobic Exercise Intervention
2016
N/A
~160

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,722 Previous Clinical Trials
16,342,793 Total Patients Enrolled
16 Trials studying Breast Cancer
3,228 Patients Enrolled for Breast Cancer
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,723 Total Patients Enrolled
49 Trials studying Breast Cancer
110,632 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,925,701 Total Patients Enrolled
939 Trials studying Breast Cancer
1,543,207 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~17 spots leftby Apr 2025